ERIS Lifesciences Ltd

ERIS Lifescience Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

ERIS Lifesciences Ltd

₹ 1,283 -1.19%
06 Jan 9:31 a.m.
eris.co.in BSE: 540596 NSE: ERIS
About

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]

Key Points

Market Position
The company is a leading player in the domestic branded formulations market. It is the youngest among the top 20 companies in the Indian Pharmaceutical Market. [1]

Website BSE NSE
  • Market Cap ₹ 17,464 Cr.
  • Current Price ₹ 1,283
  • High / Low ₹ 1,594 / 809
  • Stock P/E 150
  • Book Value ₹ 189
  • Dividend Yield 0.00 %
  • ROCE 10.1 %
  • ROE 12.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.6% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Part of BSE 250 SmallCap Index Nifty 500 Multicap 50:25:25 BSE 400 MidSmallCap Index Nifty Total Market BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
323 305 282 329 355 332 315 411 410 324 341 457 437
186 182 181 203 214 206 203 256 265 250 262 333 294
Operating Profit 137 123 102 126 141 126 111 156 144 74 79 123 143
OPM % 42% 40% 36% 38% 40% 38% 35% 38% 35% 23% 23% 27% 33%
8 6 9 3 6 3 4 4 7 3 20 5 6
Interest 1 1 1 7 7 3 3 7 7 15 29 56 56
Depreciation 12 14 15 15 16 16 17 20 25 28 29 46 46
Profit before tax 132 114 95 107 124 110 96 133 120 35 42 27 46
Tax % 10% 9% 8% 11% 7% 10% 8% 16% 2% 9% 5% 36% 39%
120 104 87 96 115 99 88 111 118 32 40 17 28
EPS in Rs 8.81 7.66 6.38 7.03 8.47 7.31 6.46 8.14 8.66 2.33 2.90 1.25 2.06
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
417 520 548 605 713 761 897 1,020 1,109 1,216 1,331 1,487 1,559
325 436 437 435 442 445 562 661 691 727 825 1,031 1,139
Operating Profit 92 84 111 171 271 316 334 359 417 488 506 456 420
OPM % 22% 16% 20% 28% 38% 42% 37% 35% 38% 40% 38% 31% 27%
1 9 7 3 25 28 32 11 10 25 16 33 35
Interest 0 0 0 0 1 10 23 2 1 3 21 57 156
Depreciation 2 4 15 20 21 22 32 45 38 51 65 102 149
Profit before tax 90 89 103 154 274 312 312 324 389 459 437 329 149
Tax % 27% 27% 19% 10% 9% 6% 8% 10% 10% 9% 9% 9%
66 65 83 138 248 294 285 291 351 417 398 300 116
EPS in Rs 4,785.45 4,738.18 6,060.36 10,034.18 18.05 21.36 20.75 21.45 25.82 30.69 29.27 22.03 8.54
Dividend Payout % 0% 0% 0% 61% 0% 0% 0% 13% 21% 20% 25% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 11%
3 Years: 10%
TTM: 6%
Compounded Profit Growth
10 Years: 17%
5 Years: 1%
3 Years: -5%
TTM: -72%
Stock Price CAGR
10 Years: %
5 Years: 21%
3 Years: 20%
1 Year: 39%
Return on Equity
10 Years: 24%
5 Years: 20%
3 Years: 18%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.14 0.14 0.14 0.14 14 14 14 14 14 14 14 14 14
Reserves 119 184 267 305 561 854 1,142 1,286 1,562 1,905 2,208 2,510 2,563
0 0 1 0 0 376 176 0 0 0 317 2,529 2,577
55 83 86 96 82 126 138 183 179 232 245 296 334
Total Liabilities 174 268 354 402 657 1,370 1,470 1,483 1,755 2,150 2,784 5,350 5,488
15 64 61 65 92 490 484 601 584 642 898 1,516 2,503
CWIP 0 0 0 0 0 0 3 4 2 3 0 1 0
Investments 58 98 182 206 381 546 580 320 531 778 997 1,619 1,883
101 106 110 131 184 335 403 558 638 728 889 2,214 1,101
Total Assets 174 268 354 402 657 1,370 1,470 1,483 1,755 2,150 2,784 5,350 5,488

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
40 90 92 133 210 236 216 265 395 369 322 336
-41 -85 -94 -45 -199 -593 2 127 -348 -268 -513 -2,492
-1 -0 1 -84 -18 363 -221 -334 -81 -88 194 2,160
Net Cash Flow -1 5 -1 4 -6 7 -2 58 -34 13 3 4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 15 16 16 15 21 29 31 50 37 41 63 59
Inventory Days 193 130 181 156 161 194 206 145 119 155 98 119
Days Payable 71 93 121 88 86 266 207 200 159 177 128 181
Cash Conversion Cycle 137 52 75 84 97 -43 30 -4 -3 19 33 -3
Working Capital Days 40 11 13 8 31 2 -22 58 65 80 82 89
ROCE % 105% 56% 44% 53% 62% 35% 26% 24% 27% 27% 20% 10%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
52.66% 52.66% 52.30% 52.29% 52.70% 52.86% 52.86% 54.91% 54.90% 54.90% 54.88% 54.87%
13.34% 13.31% 15.35% 15.39% 15.50% 14.86% 13.78% 13.20% 13.13% 14.27% 14.59% 8.01%
10.37% 10.50% 10.66% 10.69% 9.95% 10.02% 10.73% 14.52% 14.55% 15.63% 16.23% 18.64%
23.62% 23.52% 21.69% 21.63% 21.85% 22.27% 22.63% 17.37% 17.41% 15.20% 14.30% 18.47%
No. of Shareholders 54,22357,06151,63948,05546,74645,93144,16942,24546,49651,75344,17646,346

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls